Close Menu
Chicago News Journal
    Facebook X (Twitter) Instagram
    • Contact us
    • About us
    • Amazon Disclaimer
    • DMCA / Copyrights Disclaimer
    • Privacy Policy
    • Terms and Conditions
    Facebook X (Twitter) Instagram YouTube TikTok
    Chicago News JournalChicago News Journal
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • LifeStyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About us
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Privacy Policy
      • Terms and Conditions
    Chicago News Journal
    Home»Business

    Novo Nordisk’s Ozempic can be made for less than $5 a month: study

    AdminBy AdminMarch 28, 2024 Business
    Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram
    Novo Nordisk’s Ozempic can be made for less than $5 a month: study

    A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. 

    Lee Smith | Reuters

    The blockbuster diabetes drug Ozempic could be manufactured for less than $5 a month, even as Novo Nordisk charges close to $1,000 per month for the injection in the U.S. before insurance, a study released Wednesday suggests.

    The study, from researchers at Yale University, King’s College Hospital in London and the nonprofit Doctors Without Borders, raises more questions about the hefty price tag of the top-selling diabetes treatment and similar drugs for weight loss, which are all part of a new class of treatments called GLP-1s.

    Demand for those medicines has soared over the last year, even as more insurers drop them from their plans due to cost, leaving some patients unable to afford the drugs. 

    The study also comes after years of political pressure on Novo Nordisk and other drugmakers to slash high costs of diabetes care, especially insulin. 

    Ozempic can generally be produced for less than various forms of insulin, according to the study published in JAMA Network Open. 

    More CNBC health coverage

    Researchers found that a month’s supply of the treatment could be manufactured for an estimated 89 cents to $4.73. They evaluated manufacturing costs for the weekly injection along with a profit margin with an allowance for tax to produce those estimates, which they call “cost-based prices.” 

    Novo Nordisk’s list price for a monthly package of Ozempic is $935.77 before insurance and other rebates. The findings suggest that GLP-1s “can likely be manufactured for prices far below current prices, enabling wider access,” the researchers concluded. 

    In a statement on Wednesday, Novo Nordisk declined to provide production costs for Ozempic and its weight loss drug counterpart Wegovy. But the Danish drugmaker noted that it spent almost $5 billion on research and development last year, and will spend more than $6 billion on a recent deal to boost manufacturing to meet demand for GLP-1s.

    It also said 75% of its gross earnings go to rebates and discounts to ensure patients have access to its products. 

    The company also said out-of-pocket costs for Ozempic depend on a patient’s insurance coverage. Patients with private or commercial coverage for Ozempic can access a savings card and pay as little as $25 for a one-month, two-month or three-month supply of the treatment for up to 24 months. 

    Separate research from the University of Liverpool and other researchers has found that Wegovy could be produced for $40 a month.

    A survey released this month from Evercore ISI found that more than half of people currently taking a GLP-1 said they are paying a monthly price of $50 or less out of pocket. Nearly 75% of respondents who used to take one of the drugs said they spent the same amount.

    Don’t miss these stories from CNBC PRO:

    Read the original article here

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram

    You might also be interested in...

    Anthropic prices IPO at $83 a share, blowing past target range: report

    November 19, 2026

    California DMV boots Waymo robotaxis off state freeways after string of incidents

    November 18, 2026

    Chipotle launches Sneak It In hoodies with hidden pouch to keep your burrito warm

    November 17, 2026

    Big-ticket holiday items may be harder to find as shipping costs rise

    November 16, 2026

    Jensen Huang weighs Nvidia CEO comeback as ally plans war room: report

    November 16, 2026

    New Orleans port seeks tanker seizure after cruise ship crash sparks $1M lawsuit

    November 15, 2026
    Popular Posts

    Interview with Aletheia von Gottlieb, Author of Love Off the Ice (Sweet Snowfall Kisses Book 1) – NewInBooks

    What Were Wearing: Friendsgiving

    In historic move, House Democrats nominate Hakeem Jeffries for speaker of the House

    Book Riots Deals of the Day for November 18, 2026

    Voyager 1 at one light-day: Historian revisits Golden Record's forgotten details

    DWTS Fans Discover Sneaky Loophole To Rig Votes For Favorite

    Categories
    • Books (2,456)
    • Business (3,449)
    • Events (34)
    • Film (1,062)
    • LifeStyle (2,922)
    • Music (2,796)
    • Politics (2,355)
    • Science (1,951)
    • Technology (1,817)
    • Television (3,628)
    • US News (3,293)
    Archives
    Useful Links
    • Contact us
    • About us
    • Amazon Disclaimer
    • DMCA / Copyrights Disclaimer
    • Privacy Policy
    • Terms and Conditions
    Popular Posts
    • I’ve got a load of new songs alreadyI’ve got a load of new songs already
    • Best 4th of July MoviesBest 4th of July Movies
    • Can you solve this quantum cryptic word search? – Physics WorldCan you solve this quantum cryptic word search? – Physics World
    • Midsummer Box Office Hitting $1.88 Billion, -2% From 2022
    • Amaarae Announces North American TourAmaarae Announces North American Tour
    Archives
    Categories
    • Books
    • Business
    • Events
    • Film
    • LifeStyle
    • Music
    • Politics
    • Science
    • Technology
    • Television
    • US News
    Facebook X (Twitter) Instagram YouTube TikTok
    © 2026 Chicago News Journal. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms of Use and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.